JPRN-UMIN000004290招募中未知
sodium pyruvate therapy for the patients with citrin deficiency - pyruvate therapy for citrin deficiency
Working group for citrin deficiency0 个研究点目标入组 30 人开始时间: 2010年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) pregnant woman
研究者
相似试验
已完成
不适用
Sodium pyruvate therapy for the patients with citrin deficiencycitrin deficiencyJPRN-UMIN000008528Department of Pediatrics, Kobe university Graduate School of Medicine6
已完成
不适用
Sivelestat Sodium Hydrate Treatment for Patients with Kawasaki Disease refractory to initial intravenous immunoglobulin therapyKawasaki DiseaseJPRN-UMIN000013018Department of Pediatrics, Chiba University Hospital45
进行中（未招募）
不适用
A SU011248 TREATMENT PROTOCOL FOR PATIENTS WITH CYTOKINE-REFRACTORY METASTATIC RENAL CELL CARCINOMA WHO ARE INELIGIBLEFOR PARTICIPATION IN OTHER SU011248 PROTOCOLS AND MAY DERIVEBENEFIT FROM TREATMENT WITH SU011248Histopathologically confirmed renal cell carcinoma with metastasesMedDRA version: 8.0Level: LLTClassification code 10038415EUCTR2005-002097-30-ATPfizer Corporation Austria Ges.m.b.H.1,000
进行中（未招募）
不适用
A SU011248 TREATMENT PROTOCOL FOR PATIENTS WITH CYTOKINE- REFRACTORY METASTATIC RENAL CELL CARCINOMA WHO ARE INELIGIBLE FOR PARTICIPATION IN OTHER SU011248 PROTOCOLS AND MAY DERIVE BENEFIT FROM TREATMENT WITH SU011248Histopathologically confirmed renal cell carcinoma with metastasesMedDRA version: 8.0Level: LLTClassification code 10038415EUCTR2005-002097-30-IEPfizer Inc.1,000
已完成
2 期
Effect of citrate-phosphate-Dextrose Solution on reperfusion Injury in Coronary Artery Bypass Surgical Patient Undergoing Cardiopulmonary Bypasscardiac.Infection and inflammatory reaction due to other cardiac and vascular devices, implants and graftsIRCT201108147325N1Vice Chancellor, Tabriz University of Medical Sciences50